Atlas Trials

Post Marketing Surveillance of Safety and Efficacy for Cholib in Korean Patients Under the "New Drug Re-examination".

Clinical trial NCT02489331 · COMPLETED

Trial details

NCT number
NCT02489331
Sponsor
Abbott
Status
COMPLETED
Study type
OBSERVATIONAL
Dyslipidemias
Start date
2015-07-01
Primary completion
2020-11-10
Enrollment
193

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.